Literature DB >> 36274134

LncRNA PCED1B-AS1 knockdown inhibits osteosarcoma via methylation-mediated miR-10a downregulation.

Bing Wang1, Li Yao1, Yuefu Dong1, Jian Liu1, Jian Wu2.   

Abstract

BACKGROUND: LncRNA PCED1B-AS1 (PCED1B-AS1) promotes glioma. This study aimed to investigate its role in osteosarcoma (OS).
METHODS: The study included 60 OS patients. Accumulation of miR-10a and PCED1B-AS1 in tissues from OS patients and cell lines was determined by RT-qPCR. Cell transfections were performed for interaction analysis. Participation of PCED1B-AS1 siRNA silencing and miR-10a overexpression in proliferation, invasion, and migration of U2OS and MG-63 cells was analyzed by cell proliferation assay and Transwell assay.
RESULTS: PCED1B-AS1 level was increased in OS and positively correlated with miR-10a level. In OS cells, PCED1B-AS1 siRNA silencing downregulated miR-10a. Methylation-specific PCR analysis showed that PCED1B-AS1 siRNA silencing decreased the methylation of miR-10a gene promoter. Moreover, PCED1B-AS1 siRNA silencing suppressed OS cell proliferation, invasion, and migration. In addition, miR-10a overexpression attenuated the effects of PCED1B-AS1 siRNA silencing.
CONCLUSION: PCED1B-AS1 knockdown may inhibit OS cell proliferation and movement by regulating miR-10 gene methylation.
© 2022. The Author(s).

Entities:  

Keywords:  Methylation; Osteosarcoma; PCED1B-AS1; Proliferation; miR-10a

Year:  2022        PMID: 36274134     DOI: 10.1186/s13018-022-03284-1

Source DB:  PubMed          Journal:  J Orthop Surg Res        ISSN: 1749-799X            Impact factor:   2.677


  3 in total

Review 1.  Advances in targeted therapy for osteosarcoma.

Authors:  Wenya Zhou; Mengze Hao; Xiaoling Du; Kexin Chen; Guowen Wang; Jilong Yang
Journal:  Discov Med       Date:  2014-06       Impact factor: 2.970

2.  Molecular genetics and targeted therapy of WNT-related human diseases (Review).

Authors:  Masuko Katoh; Masaru Katoh
Journal:  Int J Mol Med       Date:  2017-07-19       Impact factor: 4.101

3.  miRNA-10a promotes cancer cell proliferation in oral squamous cell carcinoma by upregulating GLUT1 and promoting glucose metabolism.

Authors:  Yuan-Hua Chen; Yu Song; Yan-Ling Yu; Wei Cheng; Xin Tong
Journal:  Oncol Lett       Date:  2019-04-16       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.